Arrowhead Research Corporation

January 23, 2015January 23, 2015

Arrowhead’s Chronic HBV Infection Therapy Study Approved

News

Arrowhead Research Corporation has been cleared to start its modified multiple-dose study of ARC-520 in patients who suffer from chronic hepatitis B infection by the U.S. Food and Drug Administration (FDA). The ... Read more

October 9, 2014October 9, 2014

Anticipation Grows Over New Data For Experimental Hepatitis B Therapy

Hepatitis B, News

There is a great deal of anticipation surrounding the latest results from Arrowhead Research Corporation, who are preparing to present the latest results from their ongoing Phase 2a trial of ARC-520, their ... Read more